These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 17009970)
1. Survival in ovarian cancer in Wales: Prior to introduction of all Wales guidelines. Shylasree TS; Howells RE; Lim K; Jones PW; Fiander A; Adams M; Evans AS; Int J Gynecol Cancer; 2006; 16(5):1770-6. PubMed ID: 17009970 [TBL] [Abstract][Full Text] [Related]
2. The management of women with apparent early ovarian cancer in the south-west region of England. Olaitan A; Murdoch J; Weeks J; James J; Howe K J Obstet Gynaecol; 2002 Jul; 22(4):394-8. PubMed ID: 12521463 [TBL] [Abstract][Full Text] [Related]
3. Management of ovarian cancer: referral to a multidisciplinary team matters. Junor EJ; Hole DJ; Gillis CR Br J Cancer; 1994 Aug; 70(2):363-70. PubMed ID: 8054286 [TBL] [Abstract][Full Text] [Related]
4. Ten years' experience with centralized surgery of ovarian cancer in one health region in Norway. Aune G; Torp SH; Syversen U; Hagen B; Tingulstad S Int J Gynecol Cancer; 2012 Feb; 22(2):226-31. PubMed ID: 22080889 [TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center. Mueller JJ; Zhou QC; Iasonos A; O'Cearbhaill RE; Alvi FA; El Haraki A; Eriksson AG; Gardner GJ; Sonoda Y; Levine DA; Aghajanian C; Chi DS; Abu-Rustum NR; Zivanovic O Gynecol Oncol; 2016 Mar; 140(3):436-42. PubMed ID: 26777991 [TBL] [Abstract][Full Text] [Related]
6. Survival outcomes after extensive cytoreductive surgery and selective neoadjuvant chemotherapy according to institutional criteria in bulky stage IIIC and IV epithelial ovarian cancer. Lim MC; Yoo HJ; Song YJ; Seo SS; Kang S; Kim SH; Yoo CW; Park SY J Gynecol Oncol; 2017 Jul; 28(4):e48. PubMed ID: 28541636 [TBL] [Abstract][Full Text] [Related]
8. A Comparison of Survival Outcomes in Advanced Serous Ovarian Cancer Patients Treated With Primary Debulking Surgery Versus Neoadjuvant Chemotherapy. May T; Comeau R; Sun P; Kotsopoulos J; Narod SA; Rosen B; Ghatage P Int J Gynecol Cancer; 2017 May; 27(4):668-674. PubMed ID: 28441250 [TBL] [Abstract][Full Text] [Related]
9. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study. Petrillo M; Marchetti C; De Leo R; Musella A; Capoluongo E; Paris I; Benedetti Panici P; Scambia G; Fagotti A Am J Obstet Gynecol; 2017 Sep; 217(3):334.e1-334.e9. PubMed ID: 28549976 [TBL] [Abstract][Full Text] [Related]
10. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer. Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035 [TBL] [Abstract][Full Text] [Related]
11. National guidance on gynaecological cancer management: an audit of gynaecological cancer services and management in the South East of England. Shaw M; Wolfe C; Raju KS; Papadopoulos A Eur J Gynaecol Oncol; 2003; 24(3-4):246-50. PubMed ID: 12807233 [TBL] [Abstract][Full Text] [Related]
12. How relevant are ACOG and SGO guidelines for referral of adnexal mass? Dearking AC; Aletti GD; McGree ME; Weaver AL; Sommerfield MK; Cliby WA Obstet Gynecol; 2007 Oct; 110(4):841-8. PubMed ID: 17906018 [TBL] [Abstract][Full Text] [Related]
13. The impacts of neoadjuvant chemotherapy and of debulking surgery on survival from advanced ovarian cancer. Rosen B; Laframboise S; Ferguson S; Dodge J; Bernardini M; Murphy J; Segev Y; Sun P; Narod SA Gynecol Oncol; 2014 Sep; 134(3):462-7. PubMed ID: 25026637 [TBL] [Abstract][Full Text] [Related]
14. Developing a cancer genetics service in Wales: opinions of gynaecologists on the management of women at risk of familial ovarian cancer. Leeson S; Iredale R; Stansfield K; Evans A; Gray J Eur J Cancer Care (Engl); 2001 Sep; 10(3):172-8. PubMed ID: 11829379 [TBL] [Abstract][Full Text] [Related]
15. Optimal debulking targets in women with advanced stage ovarian cancer: a retrospective study of immediate versus interval debulking surgery. Altman AD; Nelson G; Chu P; Nation J; Ghatage P J Obstet Gynaecol Can; 2012 Jun; 34(6):558-566. PubMed ID: 22673172 [TBL] [Abstract][Full Text] [Related]
16. Simplified staging laparotomy in FIGO stage 1 epithelial ovarian cancer: follow-up and outcomes in south Wales, U.K. Beena A; Howells R; Lutchman-Singh K; Dhar K; Lim K; Jones R; Hudson E; Bertelli G J Obstet Gynaecol; 2013 Nov; 33(8):888-91. PubMed ID: 24219736 [TBL] [Abstract][Full Text] [Related]
17. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096 [TBL] [Abstract][Full Text] [Related]
18. Centralized treatment of advanced stages of ovarian cancer improves survival: a nationwide Danish survey. Fagö-Olsen CL; Høgdall C; Kehlet H; Christensen IJ; Ottesen B Acta Obstet Gynecol Scand; 2011 Mar; 90(3):273-9. PubMed ID: 21306310 [TBL] [Abstract][Full Text] [Related]
19. Efficacy of a regional network for ovarian cancer care. van Altena AM; van den Akker PA; de Hullu JA; Ottevanger PB; Aalders AL; Gerritse R; Happel M; Hoekstra MP; Janssen MJ; Samlal RA; Smeets KM; Snijders MP; Vasmel MJ; Vollebergh JH; Kiemeney LA; Massuger LF Obstet Gynecol; 2013 Sep; 122(3):668-75. PubMed ID: 23921868 [TBL] [Abstract][Full Text] [Related]
20. Patterns of palliative care referral in ovarian cancer: A single institution 5 year retrospective analysis. Nitecki R; Diver EJ; Kamdar MM; Boruta DM; Del Carmen MC; Clark RM; Goodman A; Schorge JO; Growdon WB Gynecol Oncol; 2018 Mar; 148(3):521-526. PubMed ID: 29395315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]